Unknown

Dataset Information

0

Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system.


ABSTRACT: The aberrantly expressed signal transducer and activator of transcription 3 (STAT3) predicts poor prognosis, primarily in estrogen receptor positive (ER(+)) breast cancers. Activated STAT3 is overexpressed in luminal A subtype cells. The mechanisms contributing to the prognosis and/or subtype relevant features of STAT3 in ER(+) breast cancers are through multiple interacting regulatory pathways, including STAT3-MYC, STAT3-ER?, and STAT3-MYC-ER? interactions, as well as the direct action of activated STAT3. These data predict malignant events, treatment responses and a novel enhancer of tamoxifen resistance. The inferred crosstalk between ER? and STAT3 in regulating their shared target gene-METAP2 is partially validated in the luminal B breast cancer cell line-MCF7. Taken together, we identify a poor prognosis relevant gene set within the STAT3 network and a robust one in a subset of patients. VEGFA, ABL1, LYN, IGF2R and STAT3 are suggested therapeutic targets for further study based upon the degree of differential expression in our model.

SUBMITTER: Liu LY 

PROVIDER: S-EPMC3921136 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic features of signal transducer and activator of transcription 3 in an ER(+) breast cancer model system.

Liu Li-Yu D LY   Chang Li-Yun LY   Kuo Wen-Hung WH   Hwa Hsiao-Lin HL   Lin Yi-Shing YS   Jeng Meei-Huey MH   Roth Don A DA   Chang King-Jen KJ   Hsieh Fon-Jou FJ  

Cancer informatics 20140121


The aberrantly expressed signal transducer and activator of transcription 3 (STAT3) predicts poor prognosis, primarily in estrogen receptor positive (ER(+)) breast cancers. Activated STAT3 is overexpressed in luminal A subtype cells. The mechanisms contributing to the prognosis and/or subtype relevant features of STAT3 in ER(+) breast cancers are through multiple interacting regulatory pathways, including STAT3-MYC, STAT3-ERα, and STAT3-MYC-ERα interactions, as well as the direct action of activ  ...[more]

Similar Datasets

| S-EPMC4218890 | biostudies-other
2010-11-04 | GSE24124 | GEO
| S-EPMC4366643 | biostudies-literature
| S-EPMC8993664 | biostudies-literature
| S-EPMC4041491 | biostudies-literature
| S-EPMC7103214 | biostudies-literature
| S-EPMC8745392 | biostudies-literature
| S-EPMC2654735 | biostudies-literature
| S-EPMC8283826 | biostudies-literature
| S-EPMC2659289 | biostudies-literature